173 related articles for article (PubMed ID: 3643793)
21. Heparin binding of protein-C inhibitor--analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein.
Ecke S; Geiger M; Binder BR
Eur J Biochem; 1997 Sep; 248(2):475-80. PubMed ID: 9346305
[TBL] [Abstract][Full Text] [Related]
22. Tissue kallikrein inhibitors in mammals.
Chao J; Chai KX; Chao L
Immunopharmacology; 1996 May; 32(1-3):67-72. PubMed ID: 8796269
[TBL] [Abstract][Full Text] [Related]
23. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
Harpel PC
J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
[TBL] [Abstract][Full Text] [Related]
24. Interactions in vitro and in vivo between porcine tissue kallikrein and porcine plasma proteinase inhibitors.
Bläckberg M; Ohlsson K
Scand J Clin Lab Invest; 1994 Dec; 54(8):643-51. PubMed ID: 7535946
[TBL] [Abstract][Full Text] [Related]
25. Specific identification of tissue kallikrein in exocrine tissues and in cell-free translation products with monoclonal antibodies.
Woodley CM; Chao J; Margolius HS; Chao L
Biochem J; 1985 Nov; 231(3):721-8. PubMed ID: 3907624
[TBL] [Abstract][Full Text] [Related]
26. Progressive inhibition of human glandular (urinary) kallikrein by human serum and identification of the progressive antikallikrein as alpha 1-antitrypsin (alpha 1-protease inhibitor).
Geiger R; Stuckstedte U; Clausnitzer B; Fritz H
Hoppe Seylers Z Physiol Chem; 1981 Mar; 362(3):317-25. PubMed ID: 6971794
[TBL] [Abstract][Full Text] [Related]
27. Human plasma kallikrein processing: proteolysis as an alternative control.
Motta G; Fink E; Sampaio MU; Sampaio CA
Agents Actions Suppl; 1992; 38 ( Pt 2)():265-77. PubMed ID: 1462832
[TBL] [Abstract][Full Text] [Related]
28. Interaction of human plasma kallikrein and its light chain with alpha 2-macroglobulin.
van der Graaf F; Rietveld A; Keus FJ; Bouma BN
Biochemistry; 1984 Apr; 23(8):1760-6. PubMed ID: 6202319
[TBL] [Abstract][Full Text] [Related]
29. Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid.
Nagase H; Cawston TE; De Silva M; Barrett AJ
Biochim Biophys Acta; 1982 Mar; 702(1):133-42. PubMed ID: 6279161
[TBL] [Abstract][Full Text] [Related]
30. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.
Schapira M; Scott CF; Colman RW
J Clin Invest; 1982 Feb; 69(2):462-8. PubMed ID: 6173399
[TBL] [Abstract][Full Text] [Related]
31. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
[TBL] [Abstract][Full Text] [Related]
32. Active kallikrein, preprokallikrein, and kallikrein-inhibitor complex.
Chao J; Chao L; Woodley CM; Gerald W; Margolius HS
Adv Exp Med Biol; 1986; 198 Pt A():181-7. PubMed ID: 2880478
[TBL] [Abstract][Full Text] [Related]
33. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids.
Yousef GM; Kapadia C; Polymeris ME; Borgono C; Hutchinson S; Wasney GA; Soosaipillai A; Diamandis EP
Biochim Biophys Acta; 2003 Jul; 1628(2):88-96. PubMed ID: 12890555
[TBL] [Abstract][Full Text] [Related]
34. [Purification and some physico-chemical and enzymatic properties of tissue kallikrein from human urine].
Rabinovich SE; Lobareva LS; Paskhina TS
Biokhimiia; 1990 Sep; 55(9):1675-89. PubMed ID: 2078641
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of a tissue kallikrein in rat skeletal muscles.
Shimojo N; Chao J; Chao L; Margolius HS; Mayfield RK
Biochem J; 1987 May; 243(3):773-8. PubMed ID: 3311022
[TBL] [Abstract][Full Text] [Related]
36. Kallikrein inhibitors.
Fritz H; Fink E; Truscheit E
Fed Proc; 1979 Dec; 38(13):2753-9. PubMed ID: 315885
[TBL] [Abstract][Full Text] [Related]
37. Hydrolysis of somatostatin by human tissue kallikrein after the amino acid pair phe-Phe.
Pimenta DC; Juliano MA; Juliano L
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):27-30. PubMed ID: 9355730
[TBL] [Abstract][Full Text] [Related]
38. Determination of tissue kallikrein and alpha 1-antitrypsin-tissue kallikrein complexes in synovial fluid of patients with rheumatoid, osteo and psoriatic arthritis.
Rahman MM; Worthy K; Elson CJ; Dieppe PA; Bhoola KD
Agents Actions Suppl; 1992; 38 ( Pt 3)():389-96. PubMed ID: 1462872
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of rat tissue kallikrein gene family members by rat kallikrein-binding protein and alpha 1-proteinase inhibitor.
Serveau C; Moreau T; Zhou GX; ElMoujahed A; Chao J; Gauthier F
FEBS Lett; 1992 Sep; 309(3):405-8. PubMed ID: 1445595
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.
Mikolajczyk SD; Millar LS; Marker KM; Rittenhouse HG; Wolfert RL; Marks LS; Charlesworth MC; Tindall DJ
Cancer Res; 1999 Aug; 59(16):3927-30. PubMed ID: 10463585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
